We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$181M
AUM Growth
-$925K
Cap. Flow
+$6.6M
Cap. Flow %
3.64%
Top 10 Hldgs %
18.21%
Holding
669
New
43
Increased
219
Reduced
66
Closed
46

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$586K
2
IWY icon
iShares Russell Top 200 Growth ETF
IWY
+$207K
3
PFM icon
Invesco Dividend Achievers ETF
PFM
+$200K
4
AIVI icon
WisdomTree International AI Enhanced Value Fund
AIVI
+$197K
5
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$196K

Top Sells

Rank Stock Value
1
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$197K
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$137K
3
AGGY icon
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
+$129K
4
MBB icon
iShares MBS ETF
MBB
+$122K
5
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$112K

Sector Composition

Rank Sector Weight
1 Technology 24.09%
2 Real Estate 13.58%
3 Healthcare 11.03%
4 Industrials 10.98%
5 Consumer Staples 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQD icon
476
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$4K ﹤0.01%
30
– –
MDXG icon
477
MiMedx Group
MDXG
$631M
$4K ﹤0.01%
643
– –
OTIS icon
478
Otis Worldwide
OTIS
$27.9B
$4K ﹤0.01%
43
– –
PAHC icon
479
Phibro Animal Health
PAHC
$1.4B
$4K ﹤0.01%
181
+1
+0.6% +$24
PTGX icon
480
Protagonist Therapeutics
PTGX
$9.56B
$4K ﹤0.01%
250
– –
QMCO icon
481
Quantum Corp
QMCO
$763M
$4K ﹤0.01%
34
– –
SNBR
482
DELISTED
Sleep Number
SNBR
$4K ﹤0.01%
+40
New +$3.97K
SOXX icon
483
iShares Semiconductor ETF
SOXX
$44.9B
$4K ﹤0.01%
+30
New +$4.56K
SPTI icon
484
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
$4K ﹤0.01%
133
– –
VMBS icon
485
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$4K ﹤0.01%
67
+1
+2% +$53
WSO icon
486
Watsco Inc
WSO
$13.2B
$4K ﹤0.01%
14
– –
XOMA
487
DELISTED
Xoma
XOMA
$4K ﹤0.01%
160
– –
XXII
488
22nd Century Group
XXII
$1.54M
– –
0
– –
YOLO icon
489
AdvisorShares Pure Cannabis ETF
YOLO
$32.5M
$4K ﹤0.01%
216
– –
TVRD
490
Tvardi Therapeutics
TVRD
$22.5M
$4K ﹤0.01%
7
– –
CUTR
491
DELISTED
Cutera, Inc.
CUTR
$4K ﹤0.01%
96
– –
ABMD
492
DELISTED
Abiomed Inc
ABMD
$4K ﹤0.01%
11
– –
FEO
493
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$4K ﹤0.01%
250
– –
THER
494
DELISTED
THERATECHNOLOGIES INC COM
THER
$4K ﹤0.01%
1,193
– –
ACRS icon
495
Aclaris Therapeutics
ACRS
$866M
$3K ﹤0.01%
150
– –
AKBA icon
496
Akebia Therapeutics
AKBA
$242M
$3K ﹤0.01%
900
– –
AKTX
497
Akari Therapeutics
AKTX
$13.4M
$3K ﹤0.01%
2
– –
AXGN icon
498
Axogen
AXGN
$2.62B
$3K ﹤0.01%
170
– –
BHC icon
499
Bausch Health
BHC
$2.33B
$3K ﹤0.01%
109
– –
BLUE
500
DELISTED
bluebird bio
BLUE
$3K ﹤0.01%
10
– –
18 19
20
21 22

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Truvestments Capital held 669 positions worth $181M, down 0.51% from $182M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Truvestments Capital deployed $6.6M of net new capital in Q3 2021, opening 43 new positions and adding to 219 existing holdings. Its largest new stake was Marvell Technology: 9,774 shares worth $589K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Real Estate and Healthcare.

On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $137K trimmed.

  • Truvestments Capital's largest Q3 2021 buy was Marvell Technology: 9,774 shares worth $589K.
  • Truvestments Capital added most to Vanguard Morningstar Small-Cap ETF in Q3 2021, an estimated $185K increase.
  • Truvestments Capital's biggest Q3 2021 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $137K.
  • Truvestments Capital fully exited Schwab US Aggregate Bond ETF in Q3 2021, selling an estimated $197K.
  • Truvestments Capital's ten largest holdings make up 18% of its $181M portfolio in Q3 2021.
  • Truvestments Capital opened 43 new positions and closed 46 in Q3 2021.
  • Truvestments Capital's portfolio value fell 0.51% quarter-over-quarter to $181M.

Based on Truvestments Capital's 13F filing for Q3 2021, filed 29 Oct 2021.